Catalyst Wire Dossier Catalyst Wire Dossier

insulin aspart 200 U/mL

insulin aspart · Novo Nordisk A/S
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for insulin aspart 200 U/mL, covering 2016-10-17 to 2016-10-17. Get the full timeline:

Most recent: Clinical Trial Update: Bioequivalence of Two Insulin Aspart Formulations (100 U/mL Versus 200 U/mL) [Phase 1]

See pricing